Labetalol prevents intestinal dysfunction induced by traumatic brain injury

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Lang, Yuhuang ^a   Fu, Fengming ^b   Sun, Dalong ^a   Xi, Chenhui ^a   Chen, Fengyuan ^a  

^a Urology Institute of Fudan University   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LABETALOL; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; TJP1 PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ADRENALIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG EFFICACY; DRUG RESPONSE; ENTEROPATHY; HISTOPATHOLOGY; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; ANIMAL; BRAIN INJURIES; DRUG EFFECTS; GENETICS; INTESTINE; INTESTINE ABSORPTION; METABOLISM; PATHOLOGY; WISTAR RAT;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRAIN INJURIES; INTESTINAL ABSORPTION; INTESTINES; LABETALOL; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84941332422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0133215     Document Type: Article

References (49)

1. Bansal V, Costantini T, Kroll L, Peterson C, Loomis W, Eliceiri B, et al. Traumatic brain injury and intestinal dysfunction: uncovering the neuro-enteric axis. J Neurotrauma. 2009; 26: 1353-1359. PMID: 19344293
2. Hang CH, Shi JX, Li JS, Wu W, Yin HX. Alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats. World J Gastroenterol. 2003; 9: 2776-2781. PMID: 14669332
3. Lang YH, Chen FY, Miao JF, XI Ch. Stress-related changes of intestinal mucosa barrier following graded traumatic brain injury in rats. J Trauma Surg (Chinese). 2012; 14: 51-54.
4. Wang YB, Yang ZX, Cai L. The role of apoptosis in the stress-related changes of intestinal mucosa barrier following traumatic brain injury. Chin J Int Med. 2010; 49: 869-872.
5. Hang CH, Shi JX, Li JS, Li WQ, Wu W. Expressions of intestinal NF-kappaB, TNF-alpha, and IL-6 following traumatic brain injury in rats. J Surg Res. 2005; 123: 188-193. PMID: 15680377
6. Hang CH, Shi JX, Sun BW, Li JS. Apoptosis and functional changes of dipeptide transporter (PepT1) in the rat small intestine after traumatic brain injury. J Surg Res. 2007; 37: 53-60.
7. Wang YB, Liu J, Yang ZX. Effects of intestinal mucosal blood flow and motility on intestinal mucosa. World J Gastroenterol. 2011; 17: 657-661. doi: 10.3748/wjg.v17.i5.657 PMID: 21350716
8. Baguley IJ, Heriseanu RE, Cameron ID, Nott MT, Slewa-Younan S. A critical review of the pathophysiology of dysautonomia following traumatic brain injury. Neurocrit Care. 2008; 8: 293-300. PMID: 17968518
9. Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, et al. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007; 62: 26-33; discussion 33-35. PMID: 17215730
10. MacCarthy EP, Bloomfield SS. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects. Pharmacotherapy. 1983; 3:193-219. PMID: 6310529
11. McNeil JJ, Anderson AE, Louis WJ, Morgan DJ. Pharmacokinetics and pharmacodynamic studies of labetalol in hypertensive subjects. Br J Clin Pharmacol. 1979; 8: 157-161.
12. Pedersen ME, Cockcroft JR. The vasodilatory beta-blockers. Curr Hypertens Rep. 2007; 9: 269-277. PMID: 17686376
13. Bansal V, Costantini T, Ryu SY, Peterson C, Loomis W, Putnam J, et al. Stimulating the central nervous system to prevent intestinal dysfunction after traumatic brain injury. J Trauma. 2010; 68: 1059-1064. doi: 10.1097/TA.0b013e3181d87373 PMID: 20453760
14. Bansal V, Ryu SY, Blow C, Costantini T, Loomis W, Putnam J, et al. The Hormone Ghrelin Prevents Traumatic Brain Injury Induced Intestinal Dysfunction. J Neurotrauma. 2010, 27:2255-2260. doi: 10.1089/neu.2010.1372 PMID: 20858122
15. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Fleshner M. Adrenergic receptors mediate stress-induced elevations in extracellular Hsp72. J Appl Physiol. 2005, 99:1789-1795. PMID: 16037404
16. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res. 1981; 211: 67-77. PMID: 7225844
17. Jiang XW, Gao LP, Zhang Y, Wang GM, Liu, Yan CD, Sun H. A comparison of the effects of ketamine, chloral hydrate and pentobarbital sodium anesthesia on isolated rat hearts and cardiomyocytes. J Cardiovasc Med. 2011, 12:732-735
18. Maheras K J, Gow A. Increased anesthesia time using 2,2,2-tribromoethanol-chloralhydrate with low impact on mouse psychoacoustics. J Neurosci Methods 2013, 219: 61-69 doi: 10.1016/j.jneumeth. 2013.07.004 PMID: 23856212
19. Tong S, Xiong NX, Shen JY. The improvement of method of intraperitoneal injection in rat anesthetization. Lab Anim Sci (Chinese). 2014; 31:52-54
20. Chen LW, Wang JS, Hwang B, Chen JS, Hsu CM. Reversal of the effect of albumin on gut barrier function in burn by the inhibition of inducible isoform of nitric oxide synthase. Arch Surg. 2003; 138: 1219-1225. PMID: 14609870
21. Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, et al. Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury. Eur Heart J. 2013; 34:1834-1845. doi: 10.1093/eurheartj/ehs011 PMID: 22307460
22. He Q, Pu J, Yuan A, Lau WB, Gao E, Koch WJ, et al. Activation of liver-X-receptor α but not liver-Xreceptor β protects against myocardial ischemia/reperfusion injury. Circ Heart Fail. 2014; 7: 1032-1041. doi: 10.1161/CIRCHEARTFAILURE.114.001260 PMID: 25277999
23. Yao T, Ying X, Zhao Y, Yuan A, He Q, Tong H, et al. Vitamin D Receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy. Antioxid Redox Signal. 2015; 22: 633-650. doi: 10.1089/ars.2014.5887 PMID: 25365634
24. Shan P, Pu J, Yuan A, Shen L, Shen L, Chai D, et al. RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells. Biochem Biophys Res Commun. 2008; 375: 628-633. doi: 10.1016/j.bbrc.2008.08.074 PMID: 18755147
25. Pu J, Mintz GS, Biro S, Lee JB, Sum ST, Madden SP, et al. Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification: novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2294 human coronary artery segments. J Am Coll Cardiol. 2014; 63: 2220-2233. doi: 10.1016/j.jacc.2014.02.576 PMID: 24681142
26. Pu J, Mintz GS, Brilakis ES, Banerjee S, Abdel-Karim AR, Maini B, et al. In vivo characterization of coronary plaques: novel findings from comparing greyscale and virtual histology intravascular ultrasound and near-infrared spectroscopy. Eur Heart J. 2012; 33: 372-383. doi: 10.1093/eurheartj/ehr387 PMID: 22019821
27. Chiu CJ, Mcardle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970; 101: 478-483. PMID: 5457245
28. Zygun DA, Kortbeek JB, Fick GH, Laupland KB, Doig CJ. Non-neurological organ dysfunction in severe traumatic brain injury. Crit Care Med. 2005; 33: 654-660. PMID: 15753760
29. Piek J, Chesnut RM, Marshall LF, Berkum-Clark MV, Klauber MR, Blunt BA, et al. Extra-cranial complications of severe head injury. J Neurosurg. 1992; 77: 901-907. PMID: 1432133
30. Vitarbo EA, Chatzipanteli K, Kinoshita K, Truettner JS, Alonso OF, Dietrich WD. Tumor necrosis factor alpha expression and protein levels after fluid percussion injury in rats: the effect of injury severity and brain temperature. Neurosurgery. 2004; 55: 416-424; discussion 424-415. PMID: 15271250
31. Hörtnagl H, Hammerle AF, Hackl JM, Brücke T, Rumpl E, Hörtnagl H. The activity of the sympathetic nervous system following severe head injury. Intensive Care Med. 1980; 6: 169-177. PMID: 7391345
32. Clifton GL, Ziegler MG, Grossman RG. Circulating catecholamines and sympathetic activity after head injury. Neurosurgery 1981; 8: 10-14. PMID: 7207763
33. Morel DR, Forster A, Suter PM. Evaluation of I.V. labetalol for treatment of posttraumatic hyperdynamic state. Int Care Med. 1984; 10: 133-137.
34. Elenkov IJ, Hasko G, Kovacs KJ, Vizi ES. Modulation of liposaccharide-induced tumor necrosis factoralpha production by selective alpha and beta-adrenergic drugs in mice. J Neuroimmunol. 1995; 61: 123-131. PMID: 7593548
35. Prass K, Meisel C, Höflich C, Braun J, Halle E, Wolf T, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post stroke T helper cell type 1-like immunostimulation. J Exp Med. 2003; 98: 725-736.
36. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell. 1996; 84: 345-357. PMID: 8608588
37. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol. 1993; 123: 1777-1788. PMID: 8276896
38. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998; 141: 1539-1550. PMID: 9647647
39. Ikenouchi J, Furuse M, Furuse K, Sasaki H, Tsukita S, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol. 2005; 171: 939-945. PMID: 16365161
40. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol. 1986; 103: 755-766. PMID: 3528172
41. Gumbiner B, Lowenkopf T, Apatira D. Identification of a160-kDa polypeptide that binds to the tight junction protein ZO-1. Proc Natl Acad Sci. 1991; 88: 3460-3464. PMID: 2014265
42. Haskins J, Gu L, Wittchen ES, Hibbard J, Stevenson BR. ZO-3, a novel member of the MAGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol. 1998; 141: 199-208. PMID: 9531559
43. Adachi M, Inoko A, Hata M, Furuse K, Umeda K, Itoh M, et al. Normal establishment of epithelial tight junctions in mice and cultured cells lacking expression of ZO-3, a tight-junction MAGUK protein. Mol Cell Biol. 2006; 26: 9003-9015. PMID: 17000770
44. Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, Nakayama M, et al. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell. 2006; 126: 741-754. PMID: 16923393
45. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009; 49: 1877-1887. doi: 10.1002/hep.22848 PMID: 19291785
46. Chavez AM, Menconi MJ, Hodin RA, Fink MP. Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide. Crit Care Med. 1999; 27: 2246-2251. PMID: 10548215
47. Costantini TW, Loomis WH, Putnam JG, Drusinsky D, Deree J, Choi S, et al. Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins. Shock. 2009; 31: 416-422. doi: 10.1097/SHK.0b013e3181863080 PMID: 18791495
48. Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, et al. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology. 2006; 131: 1153-1163. PMID: 17030185
49. Zacharia J, Mauban JR, Raina H, Fisher SA, Wier WG. High vascular tone of mouse femoral arteries in vivo is determined by sympathetic nerve activity via α1A- and α1D-adrenoceptor subtypes. PLoS One. 2013 Jun 12; 8(6):e65969. doi: 10.1371/journal.pone.0065969. Print 2013. PMID: 23776582